| DESCRIPTION | - 0. COSTU ET AL., JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, (2008), vol. 12, no. 3, pages 995 - 1004 | - |
| DESCRIPTION | - BALATONI ET AL., BRAIN RESEARCH BULLETIN, (2007), vol. 74, pages 307 - 316 | - |
| DESCRIPTION | - BAUMRUKER ET AL., EXPERT OPIN. INVESTIG. DRUGS, (2007), vol. 16, pages 283 - 289 | - |
| DESCRIPTION | - BAUMRUKER ET AL., EXPERT. OPIN. INVESTIG. DRUGS, (2007), vol. 16, pages 283 - 289 | - |
| DESCRIPTION | - BERGE ET AL., JOURNAL OF PHARMACEUTICAL SCIENCES,, (1977), vol. 66, pages 1 - 19 | - |
| DESCRIPTION | - BOLICK ET AL., ARTERIOSCLER. THROMB. VASC. BIOL., (2005), vol. 25, pages 976 - 981 | - |
| DESCRIPTION | - BRINKMANN ET AL., J. BIOL. CHEM., (2002), vol. 277, pages 21453 - 21457 | - |
| DESCRIPTION | - BRINKMANN ET AL., PHARMACOLOGY & THERAPEUTICS, (2007), vol. 115, pages 84 - 105 | - |
| DESCRIPTION | - BRINKMANN ET AL., TRANSPLANTATION, (2001), vol. 72, pages 764 - 769 | - |
| DESCRIPTION | - BRINKMANN ET AL., TRANSPLANT PROC., (2001), vol. 33, pages 530 - 531 | - |
| DESCRIPTION | - BRINKMANN ET AL., TRANSPLANT. PROC., (2001), vol. 33, pages 530 - 531 | - |
| DESCRIPTION | - BRINKMANN, PHARMACOLOGY & THERAPEUTICS, (2007), vol. 115, pages 84 - 105 | - |
| DESCRIPTION | - BUDDE ET AL., J. AM. SOC. NEPHROL., (2002), vol. 13, pages 1073 - 1083 | - |
| DESCRIPTION | - CHIBA ET AL., CELL MOL. BIOL., (2006), vol. 3, pages 11 - 19 | - |
| DESCRIPTION | - CHIBA, PHARMACOLOGY & THERAPEUTICS, (2005), vol. 108, pages 308 - 319 | - |
| DESCRIPTION | - CHUN ET AL., PHARMACOLOGICAL REVIEWS, (2002), vol. 54, pages 265 - 269 | - |
| DESCRIPTION | - COELHO ET AL., J. PHARMACOL. EXP. THER., (2007), vol. 323, pages 626 - 635 | - |
| DESCRIPTION | - DANIEL ET AL., J. IMMUNOL., (2007), vol. 178, pages 2458 - 2468 | - |
| DESCRIPTION | - DEGUCHI ET AL., ONCOLOGY REPORTS, (2006), vol. 16, pages 699 - 703 | - |
| DESCRIPTION | - DEV ET AL., PHARMACOLOGY AND THERAPEUTICS, (2008), vol. 117, pages 77 - 93 | - |
| DESCRIPTION | - D. NAKASHIMA ET AL., J. INVESTIGATIVE DERMATOLOGY, (2008), vol. 128, no. 12, pages 2833 - 2841 | - |
| DESCRIPTION | - E. BAR-HAIM ET AL., PLOS PATHOGENS, (20081121), vol. 4, no. 11, page E1000211 | - |
| DESCRIPTION | - FU ET AL., TRANSPLANTATION, (2002), vol. 73, pages 1425 - 1430 | - |
| DESCRIPTION | - FUJII ET AL., AM. J. PHYSIOL. GASTROINTEST. LIVER PHYSIOL., (2006), vol. 291, pages G267 - G274 | - |
| DESCRIPTION | - FUJINO ET AL., J. PHARMACOL. EXP. THER., (2003), vol. 305, pages 70 - 77 | - |
| DESCRIPTION | - FUJISHIRO ET AL., J. HEART LUNG TRANSPLANT, (2006), vol. 25, pages 825 - 833 | - |
| DESCRIPTION | - "Generation of Polymorphs, Hydrates, Solvates, and Amorphous Solids", K.J. GUILLORY, Polymorphism in Pharmaceutical Solids, MARCEL DEKKER, INC., (1999), vol. 95, pages 202 - 209 | - |
| DESCRIPTION | - GERGELY ET AL., BR J PHARMACOL, (2012), vol. 167, no. 5, pages 1035 - 1047 | - |
| DESCRIPTION | - HALE ET AL., BIOORG. MED. CHEM. LETT., (2004), vol. 14, pages 3351 - 3355 | - |
| DESCRIPTION | - HERZINGER ET AL., AM. J. CLIN. DERMATOL., (2007), vol. 8, pages 329 - 336 | - |
| DESCRIPTION | - HWANG ET AL., CIRCULATION, (1999), vol. 100, pages 1322 - 1329 | - |
| DESCRIPTION | - IDZKO ET AL., J. CLIN. INVEST., (2006), vol. 116, pages 2935 - 2944 | - |
| DESCRIPTION | - JOHAN GROENEVELD, VASCUL. PHARMACOL., (2003), vol. 39, pages 247 - 256 | - |
| DESCRIPTION | - JUNG ET AL., GLIA, (2007), vol. 55, pages 1656 - 1667 | - |
| DESCRIPTION | - KANEIDER ET AL., FASEB ./, (2004), vol. 18, pages 309 - 311 | - |
| DESCRIPTION | - KAPPOS ET AL., N. ENGL. J. MED., (2006), vol. 355, pages 1124 - 1140 | - |
| DESCRIPTION | - KATAOKA ET AL., CELLULAR & MOLECULAR IMMUNOLOGY, (2005), vol. 2, pages 439 - 448 | - |
| DESCRIPTION | - KAUDEL ET AL., TRANSPLANT. PROC., (2007), vol. 39, pages 499 - 502 | - |
| DESCRIPTION | - KEUL ET AL., ARTERIOSCLER. THROMB. VASC. BIOL., (2007), vol. 27, pages 607 - 613 | - |
| DESCRIPTION | - KIM ET AL., CELL SIGNAL, (2004), vol. 16, pages 89 - 95 | - |
| DESCRIPTION | - KIMURA ET AL., STEM CELLS, (2007), vol. 25, pages 115 - 124 | - |
| DESCRIPTION | - KIYABAYASHI ET AL., J. CARDIOVASC. PHARMACOL., (2000), vol. 35, pages 410 - 416 | - |
| DESCRIPTION | - KOHNO ET AL., BIOL. PHARM. BULL., (2004), vol. 27, pages 1392 - 1396 | - |
| DESCRIPTION | - KORECK ET AL., DERMATOLOGY, (2003), vol. 206, pages 96 - 105 | - |
| DESCRIPTION | - KOVARIK ET AL., J CLIN PHARMACOL, (2004), vol. 44, no. 5, pages 532 - 537 | - |
| DESCRIPTION | - KUROSE ET AL., EXP. EYE RES., (2000), vol. 70, pages 7 - 15 | - |
| DESCRIPTION | - LAMONTAGNE ET AL., CANCER RES., (2006), vol. 66, pages 221 - 231 | - |
| DESCRIPTION | - LEE ET AL., CLIN. CANCER RES., (2005), vol. 11, page 84588466 | - |
| DESCRIPTION | - LIMA ET AL., TRANSPLANT PROC., (2004), vol. 36, pages 1015 - 1017 | - |
| DESCRIPTION | - LIU ET AL., MICROSURGERY, (2007), vol. 27, pages 300 - 304 | - |
| DESCRIPTION | - MAKI ET AL., TRANSPLANTATION, (2002), vol. 74, pages 1684 - 1686 | - |
| DESCRIPTION | - MAKI ET AL., TRANSPLANTATION, (2005), vol. 79, pages 1051 - 1055 | - |
| DESCRIPTION | - MARTINI ET AL., AM. J. PHYSIOL. RENAL PHYSIOL., (2007), vol. 292, pages F1761 - F1770 | - |
| DESCRIPTION | - MARTINI ET AL., EXPERT OPIN. INVESTIG. DRUGS, (2007), vol. 16, pages 505 - 518 | - |
| DESCRIPTION | - MATLOUBIAN ET AL., NATURE, (2004), vol. 427, page 355 | - |
| DESCRIPTION | - MATLOUBIAN ET AL., NATURE, (2004), vol. 427, pages 355 - 360 | - |
| DESCRIPTION | - MATSUURA ET AL., INFLAMM. RES., (2000), vol. 49, pages 404 - 410 | - |
| DESCRIPTION | - MATSUURA ET AL., INT. J. IMMUNOPHARMACOL., (2000), vol. 22, pages 323 - 331 | - |
| DESCRIPTION | - MIRON ET AL., ANN. NEUROL., (2008), vol. 63, pages 61 - 71 | - |
| DESCRIPTION | - MIYAMOTO ET AL., J. AM. COLL. CARDIOL., (2001), vol. 37, pages 1713 - 1718 | - |
| DESCRIPTION | - MIZUSHIMA ET AL., INFLAMM. BOWEL DIS., (2004), vol. 10, pages 182 - 192 | - |
| DESCRIPTION | - NOFER ET AL., CIRCULATION, (2007), vol. 115, pages 501 - 508 | - |
| DESCRIPTION | - OGAWA ET AL., BBRC, (2007), vol. 361, pages 621 - 628 | - |
| DESCRIPTION | - OKAZAKI ET AL., J. RHEUMATOL., (2002), vol. 29, pages 707 - 716 | - |
| DESCRIPTION | - OO ET AL., J. BIOL. CHEM., (2007), vol. 282, pages 9082 - 9089 | - |
| DESCRIPTION | - PAN ET AL., CHEMISTRY & BIOLOGY, (2006), vol. 13, pages 1227 - 1234 | - |
| DESCRIPTION | - PREMENKO-LANIER ET AL., NATURE, (2008), vol. 454, page 894 | - |
| DESCRIPTION | - RAUSCH ET AL., J. MAGN. RESON. IMAGING, (2004), vol. 20, pages 16 - 24 | - |
| DESCRIPTION | - RAVENEY ET AL., ARCH. OPHTHALMOL., (2008), vol. 126, no. 10, page 1390 | - |
| DESCRIPTION | - ROSEN ET AL., IMMUNOL. REV., (2003), vol. 195, pages 160 - 177 | - |
| DESCRIPTION | - SAKAGAWA ET AL., TRANSPL. IMMUNOL., (2004), vol. 13, pages 161 - 168 | - |
| DESCRIPTION | - SANNA ET AL., J. BIOL. CHEM., (2004), vol. 279, pages 13839 - 13848 | - |
| DESCRIPTION | - SANNA ET AL., NAT. CHEM. BIOL., (2006), vol. 2, pages 434 - 441 | - |
| DESCRIPTION | - SAUER ET AL., J. BIOL. CHEM., (2004), vol. 279, pages 38471 - 38479 | - |
| DESCRIPTION | - SAWICKA ET AL., J. IMMUNOL., (2003), vol. 171, pages 6206 - 6214 | - |
| DESCRIPTION | - SCHMID ET AL., J. CELL BIOCHEM., (2007), vol. 101, pages 259 - 270 | - |
| DESCRIPTION | - SCHWAB ET AL., NATURE IMMUNOL., (2007), vol. 8, pages 1295 - 1301 | - |
| DESCRIPTION | - SCHWAB ET AL., NATURE LMMUNOL., (2007), vol. 8, pages 1295 - 1301 | - |
| DESCRIPTION | - SHIMIZU ET AL., CIRCULATION, (2005), vol. 111, pages 222 - 229 | - |
| DESCRIPTION | - SUZUKI ET AL., J. HEART LUNG TRANSPLANT, (2006), vol. 25, pages 302 - 209 | - |
| DESCRIPTION | - SUZUKI ET AL., TRANSPL. IMMUNOL., (1996), vol. 4, pages 252 - 255 | - |
| DESCRIPTION | - TAYLOR ET AL., BLOOD, (2007), vol. 110, pages 3480 - 3488 | - |
| DESCRIPTION | - T. HIGUCHI; V. STELLA, Prodrugs as Novel Delivery Systems, A.C.S. SYMPOSIUM SERIES, vol. 14 | - |
| DESCRIPTION | - T. KOHONO ET AL., BIOLOGICAL & PHARMACEUTICAL BULLETIN, (2005), vol. 28, no. 4, pages 736 - 739 | - |
| DESCRIPTION | - TRUONG ET AL., AMERICAN JOURNAL OF TRANSPLANTATION, (2007), vol. 7, pages 2031 - 2038 | - |
| DESCRIPTION | - T SANCHEZ ET AL., J. BIOL. CHEM., (2003), vol. 278, no. 47, pages 47281 - 47290 | - |
| DESCRIPTION | - WEBB ET AL., J. NEUROIMMUNOL., (2004), vol. 153, pages 108 - 121 | - |
| DESCRIPTION | - WEBSTER, CUTIS, (2005), vol. 76, no. 2, pages 4 - 7 | - |
| DESCRIPTION | - WHETZEL ET AL., CIRC. RES., (2006), vol. 99, pages 731 - 739 | - |
| DESCRIPTION | - YANAGAWA ET AL., J. IMMUNOL., (1998), vol. 160, pages 5493 - 5499 | - |
| DESCRIPTION | - YAN ET AL., BIOORG. & MED. CHEM. LETT., (2006), vol. 16, pages 3679 - 3683 | - |
| DESCRIPTION | - YANG ET AL., CLINICAL IMMUNOLOGY, (2003), vol. 107, pages 30 - 35 | - |
| DESCRIPTION | - ZHANG ET AL., J. CELL. MOL. MED., (2007), vol. 11, pages 307 - 314 | - |
| DESCRIPTION | - ZHANG ET AL., MINI-REVIEWS IN MEDICINAL CHEMISTRY, (2007), vol. 7, pages 845 - 850 | - |
| EXAMINATION | - Mk Goenka ET AL, "Diagnosis of acute severe colitis", Tropical Gastroenterology, (20140801), vol. 35, no. Supplement 1, doi:10.7869/tg.175, ISSN 0250-636X, pages S1 - S8, XP055713695 | |
| INTERNATIONAL-SEARCH-REPORT | - DANIEL J. BUZARD ET AL, "Discovery of APD334: Design of a Clinical Stage Functional Antagonist of the Sphingosine-1-phosphate-1 Receptor", ACS MEDICINAL CHEMISTRY LETTERS, United States, (20141211), vol. 5, no. 12, doi:10.1021/ml500389m, ISSN 1948-5875, pages 1313 - 1317, XP055255692 [X] 1-3,34-37,40-45,53 * page 1314, column 1, lines 7-9; figures 3,4; table 3; compound 4 * * page 1316, column 2, paragraph 4 * [Y] 1-58 | |
| OPPOSITION | - Anonymous, "APD334 - Drug Candidate for Treatment of Autoimmune Diseases", Arena (accessed via the Wayback Machine), (20141230), Arena (accessed via the Wayback Machine), URL: https://web.archive.org/web/20141230192116/http://www.arenapharm.com/apd334, XP093300238 | - |
| OPPOSITION | - Anonymous, "Guidance for Industry - Bioavailability and Bioequivalence Studies Submitted in NDAs or INDs — General Considerations - DRAFT GUIDANCE ", U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), (20140301), U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), URL: https://www.fda.gov/media/88254/download, XP093276772 | - |
| OPPOSITION | - Anonymous, "GUIDELINE ON STRATEGIES TO IDENTIFY AND MITIGATE RISKS FOR FIRST-INHUMAN CLINICAL TRIALS WITH INVESTIGATIONAL MEDICINAL PRODUCTS ", European Medicines Agency, COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP), Doc. Ref.EMEA/CHMP/SWP/28367/07, (20070719), European Medicines Agency, COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP), Doc. Ref.EMEA/CHMP/SWP/28367/07 , URL: https://www.ema.europa.eu/en/strategies-identify-mitigate-risks-first-human-early-clinical-trials-investigational-medicinal-products-scientific-guideline, XP093300231 | - |
| OPPOSITION | - Anonymous, "International Nonproprietary Names for Pharmaceutical Substances (INN) - Proposed INN: List 116", WHO Drug Information, Vol. 30, No. 4, (20161209), pages 605 - 710, WHO Drug Information, Vol. 30, No. 4, URL: https://www.who.int/publications/m/item/inn-pl-116, XP093276764 | - |
| OPPOSITION | - D1a - Programme Schedule of EFMC-ISMC 2014 | - |
| OPPOSITION | - "Guidance for Industry - Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers", US Department of Heath and Human Service - FDA, pages 1 - 30, URL: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM078932.pdf, (20130131), XP002691340 | - |
| OPPOSITION | - Jones Rob, "The Discovery of APD334, A Selective S1P1 Functional Antagonist", XXIII International Symposium on Medicinal Chemistry of the European Federation for Medicinal Chemistry (EFMC-ISMC 2014), (20140908), XP093300224 | - |
| OPPOSITION | - Thomas N. Tozer, M. Rowland, "Chapter 12- Initiating and Managing Therapy", Introduction to Pharmacokinetics and Pharmacodynamics - The Quantitative Basis of Drug Therapy, Lippincott Williams & Wilkins , (20060101), page 3pp, 257, ISBN 978-0-7817-5149-0, XP055415159 | - |
| OPPOSITION | - Caroline A. Lee; Stefan Schreiber; Brian Bressler; John W. Adams; Dooman Alexander Oh; Yong Q. Tang; Jinkun Zhang; Heather Kiyomi Komori; John S. Grundy, "Safety, Pharmacokinetics, and Pharmacodynamics of Etrasimod: Single and Multiple Ascending Dose Studies in Healthy Adults", Clinical Pharmacology in Drug Development, Wiley-Blackwell Publishing Ltd., GB, GB , (20240212), vol. 13, no. 5, doi:10.1002/cpdd.1379, ISSN 2160-763X, pages 534 - 548, XP072624240 | |
| OPPOSITION | - V. Martinez; F. Pares; D. Fletcher;, "Deux cas de douleur chronique aprs anesthsie locorgionale", ANNALES FRANCAISES D'ANESTHESIE ET DE REANIMATION., MASSON, PARIS., FR, FR , (20110518), vol. 30, no. 10, doi:10.1016/j.annfar.2011.05.009, ISSN 0750-7658, pages 749 - 751, XP028314459 | |
| OPPOSITION | - Brinkmann, V.V. Pinschewer, D.D. Chiba, K.K. Feng, L.L., "FTY720: a novel transplantation drug that modulates lymphocyte traffic rather than activation", TRENDS IN PHARMACOLOGICAL SCIENCES., ELSEVIER, HAYWARTH., GB, GB , (20000201), vol. 21, no. 2, doi:10.1016/S0165-6147(99)01419-4, ISSN 0165-6147, pages 49 - 52, XP004189119 | |
| OPPOSITION | - Smith Dennis A., Beaumont Kevin, Maurer Tristan S., Di Li, "Relevance of Half-Life in Drug Design : Miniperspective", Journal of Medicinal Chemistry, American Chemical Society, US, US , (20171107), vol. 61, no. 10, doi:10.1021/acs.jmedchem.7b00969, ISSN 0022-2623, pages 4273 - 4282, XP093225040 | |
| OPPOSITION | - Shifeng Pan, Gray Nathanael S., Gao Wenqi, Mi Yuan, Fan Yi, Wang Xing, Tuntland Tove, Che Jianwei, Lefebvre Sophie, Chen Yu, Chu Alan, Hinterding Klaus, Gardin Anne, End Peter, Heining Peter, Bruns Christian, Cooke Nigel G., Nuesslein-Hildesheim Barbara, "Discovery of BAF312 (Siponimod), a Potent and Selective S1P Receptor Modulator", ACS MEDICINAL CHEMISTRY LETTERS, American Chemical Society, US, US , (20130314), vol. 4, no. 3, doi:10.1021/ml300396r, ISSN 1948-5875, pages 333 - 337, XP055263008 | |
| OPPOSITION | - Daniel J. Buzard, Sun Hee Kim, Luis Lopez, Andrew Kawasaki, Xiuwen Zhu, Jeanne Moody, Lars Thoresen, Imelda Calderon, Brett Ullman, Sangdon Han, Juerg Lehmann, Tawfik Gharbaoui, Dipanjan Sengupta, Lorene Calvano, Antonio Garrido Montalban, You-An Ma, Carleton Sage, Yinghong Gao, Graeme Semple, Jeff Edwards, Jeremy Barden, Michael Morgan, Weichao Chen, Khawja Usmani, Chuan Chen, Abu Sadeque, Ronald J. Christopher, Jayant Thatte, Lixia Fu, Michelle Solomon, David Mills, Kevin Whelan, Hussien Al-Shamma, Joel Gatlin, Minh Le, Ibragim Gaidarov, Todd Anthony, David J. Unett, Anthony Blackburn, Jaimie Rueter, Scott Stirn, Dominic P. Behan, Robert M. Jones, "Discovery of APD334: Design of a Clinical Stage Functional Antagonist of the Sphingosine-1-phosphate-1 Receptor", ACS MEDICINAL CHEMISTRY LETTERS, American Chemical Society, US, US , (20141211), vol. 5, no. 12, doi:10.1021/ml500389m, ISSN 1948-5875, pages 1313 - 1317, XP055255692 | |
| OPPOSITION | - Michael Maceyka, Sarah Spiegel, "Sphingolipid metabolites in inflammatory disease", Nature, (20140601), vol. 510, no. 7503, doi:10.1038/nature13475, pages 58 - 67, XP055689592 | |
| OPPOSITION | - John M. Kovarik; Robert Schmouder; Denise Barilla; Yibin Wang; Gerolf Kraus, "Single‐dose FTY720 pharmacokinetics, food effect, and pharmacological responses in healthy subjects", British journal of clinical pharmacology, BLACKWELL SCIENTIFIC PUBL., GB, GB , (20040323), vol. 57, no. 5, doi:10.1111/j.1365-2125.2003.02065.x, ISSN 0306-5251, pages 586 - 591, XP071598693 | |
| OPPOSITION | - Hanauer Stephen B., Feagan Brian, Wolf Douglas C., Dʼhaens Geert, Vermeire Séverine, Ghosh Subrata, Smith Heather, Cravets Matt, Frohna Paul, Aranda Richard, Gujrathi Sheila, Olson Allan, Sandborn William J., "A Randomized, Double-Blind, Placebo-Controlled Trial of Ozanimod, an Oral S1P Receptor Modulator, in Moderate to Severe Ulcerative Colitis: Results of the Maintenance Period of the TOUCHSTONE Study : 1841", AMERICAN JOURNAL OF GASTROENTEROLOGY, ELSEVIER SCIENCE INC., US, US , (20151001), vol. 110, doi:10.14309/00000434-201510001-01841, ISSN 0002-9270, page S783, XP093300243 | |
| OPPOSITION | - Wang Fangfang, Niu Xiaoye, Liu Na, Zhu Zhengying, Lin Yun, Ying Lisa, Li Haiyan, "Safety, tolerability, pharmacokinetics, and pharmacodynamics of etrasimod in healthy Chinese adults: a randomized, double-blind, placebo-controlled dose-escalation phase 1 study", Frontiers in pharmacology, Frontiers Research Foundation, CH, CH , vol. 16, doi:10.3389/fphar.2025.1523339, ISSN 1663-9812, XP093300245 | |
| OPPOSITION | - Anroopb Nair, Shery Jacob, "A simple practice guide for dose conversion between animals and human", Journal of Basic and Clinical Pharmacy, India, India , (20160501), vol. 7, no. 2, doi:10.4103/0976-0105.177703, ISSN 0976-0105, page 27, XP055407475 | |
